In a decisive move that could transform public health readiness and biosecurity measures, researchers at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) are pioneering a groundbreaking method for pathogen detection. Using molecular inversion probes (MIPs) and polymerase chain reaction (PCR), they have crafted an approach that significantly enhances the speed and accuracy of identifying pathogens, a crucial element in the timely response to infectious disease outbreaks.
MIPs are single strands of nucleic acid that act as biomolecular detectives, swiftly capturing the unique DNA patterns of organisms they encounter. These DNA patterns are then amplified using PCR, a commonly used laboratory technique. This enables the captured DNA to be compared against an extensive library of known pathogens, providing an effective detection method even in complex samples such as tissues.
This innovative technique leverages the power of multiplexing, allowing thousands of genetic targets in a single sample to be amplified. As Dr. Christopher Stefan, Chief of the Developmental Diagnostics Branch in USAMRIID’s Diagnostic Systems Division, explains, “The unique nature of the technology allows for the addition and removal of targets from the panel without compromising the efficacy of the entire platform.”
In a series of high-fidelity training scenarios, the team successfully demonstrated the suitability of this method for field use. This is a significant step towards filling a critical biosurveillance capability gap. The potential impact is staggering – quicker containment of outbreaks, more targeted treatment strategies, and a richer understanding of pathogen diversity and evolution across varied environments.
The MIPs technique has already proven effective in detecting genetic markers for antibiotic resistance and identifying highly contagious viruses such as chikungunya, findings that have led to multiple publications in scientific journals. More recently, its efficacy was showcased in the field during the U.S. Army Combat Capabilities Development Command research and development program, Far-Forward Advanced Sequencing Technologies (F-FAST).
Sponsored by the Defense Threat Reduction Agency and led by the Naval Research Laboratory, F-FAST aims to rapidly detect, analyze, and sequence biological agents at the point of exposure, bypassing the need to send samples to distant laboratories. The MIPs technique, developed by USAMRIID, stands as a powerful tool in this ambitious project.
As we stand on the cusp of a new era in pathogen detection, the development and deployment of MIPs underscore a paradigm shift in the biotech industry. Not only does it hold the promise of revolutionizing our response to infectious diseases, but it also provides a potent example of the potential of synthetic biology to reshape our world. As the story of MIPs continues to unfold, the future of public health and biosecurity looks bright indeed.
Read more from army.mil
